Asymptomatic Myeloma Prognosis
Predicts risk of progression of asymptomatic (smoldering) multiple myeloma to active myeloma or amyloidosis.
Advice
Patients with smoldering or asymptomatic MM are currently observed. However, clinical trials should be sought for appropriate patients given the rapid progress in development of novel active agents.